ITCI

Caplyta (Lumateperone)

Schizophrenia

Quarterly Sales

Exp Date

October 29, 2020 (Est.)

Amp Volatility Score

Catalyst Info & Data Links

TITLE: Caplyta (Lumaterone) for Schizophrenia Quarterly Sales


WHAT IS THE NEXT CATALYST EVENT? 

  • Quarterly Sales


WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?  

  • October 29, 2020


PRIOR DATA

PRESS RELEASES

MECHANISM OF ACTION

  • The antipsychotic activity of CAPLYTA is thought to be mediated through a combination of antagonism of serotonin 5-HT2A receptors and postsynaptic antagonism of dopamine D2 receptors

Updated by MV

Prior Data (click to view full image)

Chart

Trial Design / Revenue (click to view full image)

Chart

Recent Posts

See What The Community Is Saying - Click To See Full Post

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon